INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 160 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $432,450 | +0.9% | 31,000 | -0.1% | 0.02% | 0.0% |
| Q2 2022 | $428,593 | -15.6% | 31,035 | -0.5% | 0.02% | +5.9% |
| Q1 2022 | $507,543 | +0.0% | 31,195 | +0.2% | 0.02% | 0.0% |
| Q4 2021 | $507,352 | +9.7% | 31,145 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $462,503 | -25.8% | 31,145 | -0.2% | 0.02% | -29.2% |
| Q2 2021 | $622,964 | -13.5% | 31,195 | -0.0% | 0.02% | -22.6% |
| Q1 2021 | $720,211 | +185.7% | 31,205 | +205.8% | 0.03% | +138.5% |
| Q4 2020 | $252,064 | -46.2% | 10,205 | -9.7% | 0.01% | -51.9% |
| Q3 2020 | $468,705 | -14.0% | 11,305 | -0.7% | 0.03% | -25.0% |
| Q2 2020 | $545,216 | -22.0% | 11,380 | +2.5% | 0.04% | -37.9% |
| Q1 2020 | $699,171 | -52.6% | 11,105 | -6.7% | 0.06% | -44.8% |
| Q4 2019 | $1,475,020 | +99.3% | 11,903 | +6.7% | 0.10% | +72.1% |
| Q3 2019 | $740,246 | -16.6% | 11,155 | 0.0% | 0.06% | -18.7% |
| Q2 2019 | $887,603 | +7457.3% | 11,155 | +10523.8% | 0.08% | +7400.0% |
| Q1 2019 | $11,745 | +11.0% | 105 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $10,583 | -49.2% | 105 | -36.4% | 0.00% | -50.0% |
| Q3 2018 | $20,849 | -87.7% | 165 | -91.8% | 0.00% | -91.3% |
| Q2 2018 | $169,498 | +405.5% | 2,020 | +270.6% | 0.02% | +360.0% |
| Q1 2018 | $33,528 | -1.9% | 545 | -6.8% | 0.01% | 0.0% |
| Q4 2017 | $34,176 | – | 585 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
| CM Management, LLC | 45,000 | $668,000 | 0.50% |
| EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
| DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
| Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
| Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
| Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
| DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |